Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Chan

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Pathology|June 20, 2020
Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 casesTalia L Fuchs, Antonia Pearson, Justine Pickett, et al.
Cell Reports|June 22, 2017
OPA1 Isoforms in the Hierarchical Organization of Mitochondrial FunctionsValentina Del Dotto, Prashant Mishra, Sara Vidoni, et al.
BMJ (Clinical Research Ed.)|June 21, 2003
Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational studyTimothy H Rainer, Peter A Cameron, DeVilliers Smit, et al.
Journal of Geriatric Oncology|July 9, 2014
Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysisPeter Ward, J Randolph Hecht, He-Jing Wang, et al.
Journal of Palliative Medicine|June 1, 2016
Outpatient Advance Care Planning Internal Medicine Resident Curriculum: Valuing Our Patients' WishesDavid Chan, Elizabeth Ward, Brittany Lapin, et al.
Frontiers in Oncology|March 21, 2020
Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant ChemotherapySumit Sahni, Christopher Nahm, Christoph Krisp, et al.
Journal of Geriatric Oncology|January 30, 2014
A phase II trial of frontline capecitabine and bevacizumab in poor performance status and/or elderly patients with metastatic colorectal cancerArash Naeim, Peter R Ward, Hei-Jing Wang, et al.
Communications Biology|January 5, 2021
miR-379 deletion ameliorates features of diabetic kidney disease by enhancing adaptive mitophagy via FIS1Mitsuo Kato, Maryam Abdollahi, Ragadeepthi Tunduguru, et al.
Communications Biology|February 5, 2021
Publisher Correction: miR-379 deletion ameliorates features of diabetic kidney disease by enhancing adaptive mitophagy via FIS1Mitsuo Kato, Maryam Abdollahi, Ragadeepthi Tunduguru, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 9, 2018
Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell modelsValentina Del Dotto, Mario Fogazza, Francesco Musiani, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Pathology|June 20, 2020
Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 casesTalia L Fuchs, Antonia Pearson, Justine Pickett, et al.
Cell Reports|June 22, 2017
OPA1 Isoforms in the Hierarchical Organization of Mitochondrial FunctionsValentina Del Dotto, Prashant Mishra, Sara Vidoni, et al.
BMJ (Clinical Research Ed.)|June 21, 2003
Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational studyTimothy H Rainer, Peter A Cameron, DeVilliers Smit, et al.
Journal of Geriatric Oncology|July 9, 2014
Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysisPeter Ward, J Randolph Hecht, He-Jing Wang, et al.
Journal of Palliative Medicine|June 1, 2016
Outpatient Advance Care Planning Internal Medicine Resident Curriculum: Valuing Our Patients' WishesDavid Chan, Elizabeth Ward, Brittany Lapin, et al.
Frontiers in Oncology|March 21, 2020
Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant ChemotherapySumit Sahni, Christopher Nahm, Christoph Krisp, et al.
Journal of Geriatric Oncology|January 30, 2014
A phase II trial of frontline capecitabine and bevacizumab in poor performance status and/or elderly patients with metastatic colorectal cancerArash Naeim, Peter R Ward, Hei-Jing Wang, et al.
Communications Biology|January 5, 2021
miR-379 deletion ameliorates features of diabetic kidney disease by enhancing adaptive mitophagy via FIS1Mitsuo Kato, Maryam Abdollahi, Ragadeepthi Tunduguru, et al.
Communications Biology|February 5, 2021
Publisher Correction: miR-379 deletion ameliorates features of diabetic kidney disease by enhancing adaptive mitophagy via FIS1Mitsuo Kato, Maryam Abdollahi, Ragadeepthi Tunduguru, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 9, 2018
Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell modelsValentina Del Dotto, Mario Fogazza, Francesco Musiani, et al.
Pageof 19